Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (17) , 1213-1238
- https://doi.org/10.2165/00019053-200321170-00001
Abstract
Colorectal cancer (CRC), the third most prevalent cancer worldwide, imposes a significant economic and humanistic burden on patients and society. One study conservatively estimated the annual...Keywords
This publication has 104 references indexed in Scilit:
- Vitamin E and colon cancer: Is there an association?Nutrition and Cancer, 1998
- Whole‐grain intake and cancer: An expanded review and meta‐analysisNutrition and Cancer, 1998
- Pharmacoeconomic Evaluation of Tegafur-Uracil (UFT) vs Fluorouracil for the Management of Colorectal Cancer in Brazil and ArgentinaClinical Drug Investigation, 1997
- Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment RegimensEuropean Journal Of Cancer, 1996
- Advanced colorectal carcinoma: redefining the role of oral ftorafurAnti-Cancer Drugs, 1996
- NSAID-INDUCED POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTSGastroenterology Clinics of North America, 1996
- Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleedingGastrointestinal Endoscopy, 1995
- Chemo- and dietary prevention of colorectal cancerEuropean Journal Of Cancer, 1995
- Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA)Cancer Causes & Control, 1994
- Cost‐effective management of colon and rectal cancerWorld Journal of Surgery, 1991